In addition, combined treatment with furamidine and berbamine, a CaMKIIγ inhibitor, more effectively suppressed the growth of U87MG GSCs through the stronger downregulation of STAT3-mediated downstream GBM stemness regulators by simultaneously blocking PRMT1 and CaMKIIγ functions. The gene discussed is PRMT1; the disease is glioblastoma.